Supplementary Figure 1 from Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma

Authors :: Daniel Gioeli
Michael J. Weber
Aaron Mackey
Karin Jensen
Brian J. Capaldo
Mark Axelrod
Devin G. Roller
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file, 428K, The combination of sorafenib and diclofenac causes cell death.

Full Text Access

Tools